IRIS
FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.826
AS - Asia 1.811
EU - Europa 767
SA - Sud America 207
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 4.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.776
SG - Singapore 660
CN - Cina 565
VN - Vietnam 277
IE - Irlanda 214
SE - Svezia 210
BR - Brasile 164
HK - Hong Kong 100
TR - Turchia 69
DE - Germania 67
FR - Francia 55
NL - Olanda 48
ZA - Sudafrica 48
FI - Finlandia 43
IN - India 32
GB - Regno Unito 31
CA - Canada 28
RU - Federazione Russa 21
CI - Costa d'Avorio 20
IT - Italia 19
BD - Bangladesh 14
AR - Argentina 13
MX - Messico 12
PL - Polonia 11
PK - Pakistan 10
JP - Giappone 9
MA - Marocco 9
UA - Ucraina 8
VE - Venezuela 8
IL - Israele 7
IQ - Iraq 7
IR - Iran 7
PH - Filippine 7
RO - Romania 7
EC - Ecuador 6
BE - Belgio 5
EG - Egitto 5
EU - Europa 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
ID - Indonesia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KR - Corea 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
ES - Italia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SR - Suriname 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.714
Salva come PNG Salva come JPEG
Città #
Chandler 354
Singapore 333
Ashburn 290
Dublin 214
Santa Clara 184
San Jose 128
Beijing 125
Hong Kong 94
Ho Chi Minh City 89
Dearborn 74
Nanjing 62
Shanghai 58
Izmir 54
Hanoi 52
Johannesburg 48
Boardman 47
Princeton 42
Lauterbourg 36
Los Angeles 35
Helsinki 34
Munich 33
Dallas 32
Shenyang 32
Wilmington 26
Kunming 21
Nanchang 21
Abidjan 20
Hebei 20
New York 19
Jiaxing 18
San Mateo 18
Da Nang 17
Frankfurt am Main 17
Moscow 16
Tianjin 15
Changsha 14
Guangzhou 13
Toronto 12
São Paulo 11
Columbus 10
Jinan 10
Ann Arbor 9
Kocaeli 9
Tokyo 9
Turku 9
Biên Hòa 8
Buffalo 7
Hangzhou 7
Hefei 7
Pune 7
Seattle 7
Augusta 6
Bremen 6
Chennai 6
Fremont 6
Stockholm 6
Timisoara 6
Warsaw 6
Baghdad 5
Belo Horizonte 5
Brooklyn 5
Brussels 5
Draper 5
Edinburgh 5
Grafing 5
Haiphong 5
Hải Dương 5
London 5
Norwalk 5
Orem 5
Phoenix 5
Andover 4
Baku 4
Bexley 4
Can Tho 4
Cotia 4
Leawood 4
Montreal 4
Mumbai 4
Nairobi 4
Ningbo 4
Parma 4
Rio de Janeiro 4
Salvador 4
Shijiazhuang 4
Taizhou 4
Tashkent 4
Uberlândia 4
Wuhan 4
Asunción 3
Bangkok 3
Bishkek 3
Boston 3
Brasília 3
Budapest 3
Cambridge 3
Chengdu 3
Denver 3
Fuzhou 3
Islamabad 3
Totale 3.039
Salva come PNG Salva come JPEG
Nome #
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 155
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 152
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 150
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 140
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 138
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 135
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 133
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 131
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 130
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 128
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 126
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 126
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 122
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 122
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 121
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 121
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 120
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 119
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 119
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 118
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 115
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 114
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 114
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 113
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 112
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 111
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 111
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 110
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 108
La terapia delle malattie acido-correlate nell'anziano 106
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 106
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 102
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 100
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 89
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 88
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 86
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 82
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 82
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 79
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 76
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 75
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 62
null 10
Totale 4.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 9 28 0
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/20251.085 36 52 66 35 139 139 37 46 176 95 80 184
2025/20261.662 200 138 161 144 310 117 160 37 269 126 0 0
Totale 4.757